{"nct_id":"NCT03098030","title":"Dinutuximab and Irinotecan Versus Irinotecan to Treat Subjects With Relapsed or Refractory Small Cell Lung Cancer","status":"COMPLETED","status_verified_date":"2020-11","start_date":"2017-06-01","start_date_type":"ACTUAL","primary_completion_date":"2020-01-27","primary_completion_date_type":"ACTUAL","completion_date":"2020-03-26","completion_date_type":"ACTUAL","phases":["PHASE2","PHASE3"],"tickers":["UNH"]}